Full Text View
Tabular View
No Study Results Posted
Related Studies
Motivation and Skills for Delta-9-Tetrahydrocannabinol/Ethanol (THC/ETOH+) Teens in Jail (SMART)
This study is currently recruiting participants.
Verified by University of Rhode Island, September 2008
First Received: July 23, 2007   Last Updated: September 4, 2008   History of Changes
Sponsor: University of Rhode Island
Information provided by: University of Rhode Island
ClinicalTrials.gov Identifier: NCT00506753
  Purpose

The purpose of this study is to test the efficacy of an individual motivational interview followed by group sessions of cognitive behavior therapy for reducing alcohol and marijuana-related harm as well as alcohol and marijuana use in incarcerated teens.


Condition Intervention Phase
Alcohol Drinking
Marijuana Smoking
Behavioral: Motivation Intervention, Cognitive Behavior Therapy
Phase I
Phase II

Study Type: Interventional
Study Design: Treatment, Randomized, Double Blind (Subject, Caregiver), Active Control, Factorial Assignment, Efficacy Study
Official Title: Prison Study: Motivation and Skills for THC/ETOH+ Teens in Jail

Resource links provided by NLM:


Further study details as provided by University of Rhode Island:

Primary Outcome Measures:
  • Alcohol Use [ Time Frame: 6 months post release ] [ Designated as safety issue: No ]
  • Marijuana Use [ Time Frame: 6 month post release ] [ Designated as safety issue: No ]
  • Illegal activity and injuries while high or drunk [ Time Frame: 6 months post release ] [ Designated as safety issue: No ]

Estimated Enrollment: 267
Study Start Date: September 2004
Estimated Study Completion Date: October 2011
Estimated Primary Completion Date: October 2011 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
MI/CBT: Experimental
Motivational Intervention followed by Cognitive Behavior Therapy
Behavioral: Motivation Intervention, Cognitive Behavior Therapy
Comparison of 2 treatment combinations for assisting incarcerated teens with alcohol and marijuana use and associated problems. The two treatments being compared are, Motivational Intervention/Cognitive Behavior Therapy and Relaxation Treatment/Substance Education Treatment.

Detailed Description:

Although substance abuse is a major problem among incarcerated teens, little is known about ways to effectively treat this population. Elucidation of effective therapies for reducing substance use among incarcerated teens is important for a number of reasons. For example, a number of empirical studies have demonstrated a strong relationship between substance use and a variety of delinquent and/or dangerous activities, including driving under the influence, perpetration or falling victim to violent crime, and engaging in risky sexual behavior, as well as increases in recidivism to illegal behavior. Unfortunately, substance abuse treatment frequently is unavailable to teens in the juvenile justice system, and when it is available, treatment often is provided in group format using untested interventions, or to teens that are unmotivated to change their behavior.

The objective of the present study is to investigate ways to enhance group therapy engagement and reduce substance use (specifically targeting alcohol and marijuana) and related behaviors (e.g., injury, sexual risk-taking, and illegal behavior) among juvenile offenders. Both Motivational Interviewing (MI) and Cognitive Behavioral Therapy (CBT) have independently demonstrated success in reducing adolescent substance use in both incarcerated and non-incarcerated samples, thus a motivation and skills-based intervention such as the combination MI/CBT approach proposed here, might prove effective in attaining these goals.

  Eligibility

Ages Eligible for Study:   14 Years to 19 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Adolescents will be eligible if:

    • in the year prior to incarceration they either a) drank alcohol or used marijuana at least once per month or b) binge-drank (> 5 for boys, > 4 for girls) during any two week period
    • they drank or used marijuana in the four weeks before the offense for which they were incarcerated; or
    • they used either substance in the four weeks before they were incarcerated. Special attention will be given to recruitment of girls and members of minority groups, with periodic reminders to social workers to alert participants in these groups and their families to our project.

Exclusion Criteria:

  • They do not meet the above inclusion criteria or informed consent is not obtained from parent or guardian.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00506753

Contacts
Contact: Lynda Stein, Ph.D. 401-874-4261 LARStein@URI.EDU
Contact: Rebecca M Lebeau, Ph.D. 401-874-2518 RLebeau@uri.EDU

Locations
United States, Rhode Island
Rhode Island Training School Recruiting
Cranston, Rhode Island, United States, 02920
Sponsors and Collaborators
University of Rhode Island
Investigators
Principal Investigator: Lynda Stein, Ph.D. University of Rhode Island
  More Information

Publications:
Stein, L. A. R., Hesselbrock, V., & Bukstein, O. (in press). Disruptive behavior disorders (conduct disorder and oppositional defiant disorder) and adolescent substance abuse. In Y. Kaminer & O. G. Bukstein (Eds.), Adolescent substance abuse: Psychiatric comorbidity & high risk behaviors. Binghamton, NY: Haworth Press.

Responsible Party: University of Rhode Island ( Lynda Stein, Ph.D. )
Study ID Numbers: DA018851-02
Study First Received: July 23, 2007
Last Updated: September 4, 2008
ClinicalTrials.gov Identifier: NCT00506753     History of Changes
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Physiological Effects of Drugs
Drinking Behavior
Psychotropic Drugs
Hallucinogens
Alcohol Drinking
Marijuana Smoking
Pharmacologic Actions
Tetrahydrocannabinol
Smoking
Habits
Sensory System Agents
Analgesics, Non-Narcotic
Therapeutic Uses
Peripheral Nervous System Agents
Analgesics
Central Nervous System Agents

ClinicalTrials.gov processed this record on February 08, 2010